MARKET NEWS

Worldwide Research & Collaboration Needed to Combat Covid-19
Itamar Medical & Clalit Research Institute Establish Research Collaboration
TTP Enters Exclusive License Agreement With DiaSorin
Evelo Biosciences Announces Biomarker Data Showing Drug is Orally Delivered Dual Cytokine Inhibitor for Inflammatory Diseases
CN Bio Innovations Raises $9 Million to Strengthen Commercial Development
Bormioli Pharma Speeds Up on Innovation With H-FARM

  FEATURED EDITORIAL

  COMPANY PROFILE

Proveris Scientific is an instrument and laboratory service company that creates today’s most advanced testing solutions for orally inhaled and nasal drug product (OINDP) drug development and manufacturing. We are a leader in spray and aerosol product testing and contract services. Trusted partner in product development from early stage R&D to manufacturing. Serving pharmaceutical companies, device manufacturers, CDO/CRO/CMOs, and regulatory agencies. Click here for more.


Looking for an experienced and committed steriles CDMO? Look no further than Pii.
Pii has a strong pedigree of scientific know-how and regulatory experience across a range of dosage forms, including capacity for aseptic fill-finish. Our commitment to this market and our capabilities have grown further with investment in a new, fully-robotic aseptic filling line. With expanded capacity for small to medium-batch production of commercial and clinical materials, we are eager to discuss your needs, so we can help advance your sterile product. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Arcturus Therapeutics & Duke-NUS Medical School Partner to Develop a COVID-19 Vaccine

Arcturus Therapeutics & Duke-NUS Medical School Partner to Develop a COVID-19 Vaccine

Arcturus Therapeutics and Duke-NUS Medical School (Duke-NUS) recently announced their partnership to develop a Coronavirus….

PDC*line Pharma Announces First Patient Dosed With its Therapeutic Cancer Vaccine

PDC*line Pharma Announces First Patient Dosed With its Therapeutic Cancer Vaccine

PDC*line Pharma recently announced the first patient was dosed with its innovative medicinal product candidate PDC*lung01 in a Phase 1/2 trial in….

zPREDICTA Enters Strategic Collaboration With LabCorp

zPREDICTA Enters Strategic Collaboration With LabCorp

zPREDICTA, Inc. recently announce it has entered into a strategic collaboration with LabCorpto to support the adoption of….

ADMA Biologics Highlights Expanded Intellectual Property Portfolio

ADMA Biologics Highlights Expanded Intellectual Property Portfolio

ADMA Biologics recently announced that it has received another Notice of Allowance from the US Patent and Trademark Office (USPTO) for a patent application related to its…..

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

March 18 – Analytical Instruments
March 25 – Parenteral Contract Manufacturing